Analysts at William Blair lower their earnings forecasts for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Neurocrine Biosciences, Inc.’s NBIX Research analysts from William Blair decreased their projections for Neurocrine Biosciences’ earnings per share (EPS) for the fiscal year 2024 in …